AU2001227915A1 - Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration - Google Patents

Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration

Info

Publication number
AU2001227915A1
AU2001227915A1 AU2001227915A AU2791501A AU2001227915A1 AU 2001227915 A1 AU2001227915 A1 AU 2001227915A1 AU 2001227915 A AU2001227915 A AU 2001227915A AU 2791501 A AU2791501 A AU 2791501A AU 2001227915 A1 AU2001227915 A1 AU 2001227915A1
Authority
AU
Australia
Prior art keywords
taste
linezolid
masked
microcapsules
oral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001227915A
Other languages
English (en)
Inventor
Phillip J. Percel
Gopi M. Venkatesh
Krishna S. Vishnupad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Pharmaceuticals Holdings Ireland ULC
Original Assignee
Eurand America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand America Inc filed Critical Eurand America Inc
Publication of AU2001227915A1 publication Critical patent/AU2001227915A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001227915A 2000-01-20 2001-01-16 Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration Abandoned AU2001227915A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17723300P 2000-01-20 2000-01-20
US60177233 2000-01-20
US09506051 2000-02-17
US09/506,051 US6451345B1 (en) 2000-01-20 2000-02-17 Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
PCT/US2001/001414 WO2001052848A2 (en) 2000-01-20 2001-01-16 Functional coating of linezolid microcapsules for oral administration

Publications (1)

Publication Number Publication Date
AU2001227915A1 true AU2001227915A1 (en) 2001-07-31

Family

ID=26873062

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001227915A Abandoned AU2001227915A1 (en) 2000-01-20 2001-01-16 Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration

Country Status (6)

Country Link
US (1) US6451345B1 (de)
EP (1) EP1248616B1 (de)
AT (1) ATE357231T1 (de)
AU (1) AU2001227915A1 (de)
DE (1) DE60127379D1 (de)
WO (1) WO2001052848A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
US7488496B2 (en) 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
EP1534251A1 (de) * 2002-07-17 2005-06-01 Eurand Pharmaceuticals Ltd. Verfahren zur herstellung von pharmazeutischen mikrokapseln mit verbesserter geschmacksmaskierung und auflösungsgeschwindigkeit
ATE449598T1 (de) * 2002-07-19 2009-12-15 Aventis Pharma Sa Geschmacksmaskierte orale zubereitung von telithromycin
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
US20040208936A1 (en) * 2002-07-22 2004-10-21 Roland Chorin Novel compositions
US6875784B2 (en) * 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
US20040265372A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US20040265373A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US8168228B2 (en) * 2003-10-17 2012-05-01 Sandoz Ag Antibiotic clarithromycin micropellet compositions
US7387793B2 (en) * 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
US8545881B2 (en) 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
IS7724A (is) * 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
US20080014257A1 (en) * 2006-07-14 2008-01-17 Par Pharmaceutical, Inc. Oral dosage forms
JP5228359B2 (ja) * 2007-04-12 2013-07-03 ニプロ株式会社 主薬粒子及びその製造方法ならびに口腔内崩壊錠
FR2918296B1 (fr) 2007-07-05 2009-09-18 Oreal Capsules de type noyau/ecorce et procede de preparation
TW200938186A (en) * 2008-02-13 2009-09-16 Eurand Inc Orally disintegrating tablet compositions of ranitidine and methods of manufacture
WO2010046933A2 (en) 2008-10-22 2010-04-29 Rubicon Research Private Limited Pharmaceutical compositions of taste-masked linezolid
WO2010088385A1 (en) 2009-01-30 2010-08-05 Sepracor Inc. Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrol o [3,4-b] pyrazine and methods for measuring effectiveness of coating
WO2011080570A2 (en) 2009-12-29 2011-07-07 Micro Labs Limited Extended release pharmaceutical composition comprising linezolid and process for preparing the same
AU2011268146A1 (en) 2010-06-17 2013-01-10 Actogenix Nv Compositions and methods for treating inflammatory conditions
US20140088164A1 (en) * 2010-11-24 2014-03-27 Rib-X Pharmaceuticals, Inc. Pharmaceutical Compositions
CA2778748A1 (en) * 2011-06-01 2012-12-01 Nitto Denko Corporation Particulate preparation and method for producing the same
US10195154B2 (en) 2011-06-10 2019-02-05 Nipro Corporation Method for producing orodispersible tablets
WO2013088389A1 (en) * 2011-12-14 2013-06-20 Alembic Pharmaceuticals Limited Linezolid premix
GR1008143B (el) 2013-03-11 2014-03-14 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα περιεχον ενα οξαζολιδινονικο αντιβακτηριακο παραγοντα και μεθοδος για την παρασκευη αυτου
CN104739788B (zh) * 2013-12-27 2018-02-16 桂林南药股份有限公司 一种小儿利奈唑胺组合物冻干口腔崩解片及其制备方法
JP6572244B2 (ja) 2014-02-25 2019-09-04 オービス バイオサイエンシズ， インク．Ｏｒｂｉｓ Ｂｉｏｓｃｉｅｎｃｅｓ， Ｉｎｃ． 味覚マスキング薬製剤
CN105055354B (zh) * 2015-09-08 2017-11-21 深圳万乐药业有限公司 一种利奈唑胺片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800087A (en) 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4948801A (en) 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5082669A (en) 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
IT1246382B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5075114A (en) 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
EP0622083B1 (de) * 1993-04-28 1999-06-30 Takeda Chemical Industries, Ltd. Geschmacksmaskierte feste Zubereitung und Verfahren zur Herstellung
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
NZ504612A (en) 1997-11-18 2002-08-28 Upjohn Co Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
EP1049682A1 (de) 1998-01-23 2000-11-08 Versicor, Inc. Oxazolidinone kombinatorische bibliotheken, verfahren zu ihrer herstellung und zusammensetzungen

Also Published As

Publication number Publication date
EP1248616A2 (de) 2002-10-16
US6451345B1 (en) 2002-09-17
EP1248616B1 (de) 2007-03-21
DE60127379D1 (de) 2007-05-03
ATE357231T1 (de) 2007-04-15
WO2001052848A3 (en) 2001-12-13
WO2001052848A2 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
AU2001227915A1 (en) Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
Nagar et al. Orally disintegrating tablets: formulation, preparation techniques and evaluation
US5464632A (en) Rapidly disintegratable multiparticular tablet
CA2092074C (en) Rapidly disintegratable multiparticulate tablet
US6767557B2 (en) Taste masked pharmaceutical compositions
EP1194153B1 (de) Geschmackskaschierte flüssige arzneizubereitungen
US20080181932A1 (en) Compositions for oral delivery of pharmaceuticals
ES2201465T3 (es) Formulado de comprimidos de monohidrato de cefadroxil.
HUP0201877A2 (hu) Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák
NZ233441A (en) Medicament tablet containing a chewable base and an effervescent couple
CA2307018A1 (en) Osmotic medicament releasing system
EP1980244B1 (de) Basispartikel und im Mund zerfallende Tablette, die dieselben enthält
US20120028949A1 (en) Rapidly Disintegrating Tablet
NO329071B1 (no) Faste, hurtig desintegrerende cetirizin-formuleringer
US5702723A (en) Multi-stage delivery system for ingestible medications or nutrients
CA2457100A1 (en) Taste masking composition
US20020006433A1 (en) Pharmaceutical formulations
WO2002056867A3 (en) Extended release pharmaceutical compositions containing beta-lactam antibiotics
US9339475B2 (en) Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals